KLOW Blend

Description

The KLOW Blend is the most comprehensive recovery research stack available, combining four synergistic peptides in a single lyophilized vial: BPC-157, TB-500, GHK-Cu, and KPV. Each component targets a distinct molecular pathway involved in tissue repair, inflammation modulation, and cellular regeneration, creating a multi-vector research model that no single peptide can replicate. This premium formulation is designed for advanced research protocols requiring simultaneous investigation of complementary recovery mechanisms.

BPC-157 (Body Protection Compound-157) is a synthetic gastric pentadecapeptide that has demonstrated significant tissue repair activity across preclinical models. Its primary mechanisms include upregulation of vascular endothelial growth factor (VEGF) receptor expression, promotion of angiogenesis, and interaction with the nitric oxide system. Published research documents accelerated healing of tendons, ligaments, muscles, and gastrointestinal mucosa in rodent injury models. BPC-157 provides the foundational tissue repair component of the KLOW Blend, addressing vascular supply and structural tissue regeneration at the wound site level.

TB-500, a synthetic fragment of Thymosin Beta-4, operates through a fundamentally different mechanism centered on actin sequestration and regulation of cell migration. By binding to G-actin monomers, TB-500 promotes cytoskeletal reorganization that enables endothelial cells, keratinocytes, and other repair-associated cell types to migrate into damaged tissue. Its anti-inflammatory activity has been documented through downregulation of pro-inflammatory cytokines including IL-1beta and TNF-alpha. Where BPC-157 builds the vascular infrastructure for repair, TB-500 facilitates the cellular migration required to populate and reconstruct the damaged tissue architecture.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide that acts as a potent signaling molecule for extracellular matrix remodeling. Research has identified over 4,000 genes whose expression is modulated by GHK-Cu, with particular relevance to collagen synthesis, decorin production, and stem cell recruitment. The copper ion is integral to the peptide's activity, serving as a cofactor for lysyl oxidase, the enzyme responsible for collagen and elastin cross-linking. GHK-Cu adds a matrix remodeling and regenerative signaling dimension that complements the direct tissue repair activities of BPC-157 and TB-500.

KPV is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) consisting of the amino acid sequence Lys-Pro-Val. Despite its small size, KPV retains the potent anti-inflammatory and antimicrobial properties of the parent hormone while lacking its melanogenic effects. Research has demonstrated that KPV inhibits NF-kB nuclear translocation, a master regulator of inflammatory gene expression, and exhibits direct antimicrobial activity against several bacterial strains relevant to wound infection models. KPV provides the anti-inflammatory and antimicrobial layer of the KLOW Blend, addressing the immune and infection control aspects of the recovery environment.

The value proposition of the KLOW Blend is substantial: purchasing these four peptides individually would cost significantly more than the combined formulation, while the co-lyophilization ensures precise ratios and eliminates the variability inherent in manual reconstitution and mixing of separate vials. Each component exceeds 98% purity as verified by independent HPLC analysis. Reconstitute with bacteriostatic water prior to use in research applications.

EU Shipping: Ships from EU warehouse in 24-48h. Free shipping on orders over €100. No customs delays — intra-EU shipment. Tracked via Spring GDS / DHL EU Connect. Janoshik COA available per batch on request.

Reconstitution & Administration Protocol

The KLOW Blend co-lyophilized vial is supplied for reconstitution with bacteriostatic water (0.9% benzyl alcohol). Standard laboratory protocols are summarized below — researchers should validate against their own internal SOPs.

• Recommended diluent: Bacteriostatic Water (BAC water) with 0.9% benzyl alcohol preservative.
• Standard dilution: Add 3 ml of BAC water to the blend vial → workable concentration for typical research draw volumes (20-100 μl per dosing event).
• Alternative dilution: Add 2 ml of BAC water for more concentrated working solution if smaller draw volumes are required.
• Technique: Inject the diluent slowly along the inner wall of the vial. Do not aim directly at the powder bed. Swirl the vial gently for 60-90 seconds until fully dissolved — slightly longer than single-peptide vials because of the multi-component composition. Never shake — vigorous agitation can disrupt the GHK-Cu copper coordination chemistry and fragment the longer TB-500 chain.
• Expected appearance: Clear solution with a very pale blue tint from the GHK-Cu copper(II) complex. The pale color is normal and confirms intact GHK-Cu complex formation.
• Containers: Use copper-free, low-protein-binding polypropylene tubes for aliquoting. Avoid glass for long-term storage of working solutions.
• Typical research dosing window: 200-500 mcg of the combined blend per dosing event, 1-2 times per 24h cycle in rodent recovery models.
• Post-reconstitution stability: Store at 2-8°C protected from light. Use within 14 days — the GHK-Cu component is the rate-limiting peptide for in-solution stability. Discard if solution turns brown or develops particulates.

Stability & Half-Life Data

• BPC-157 plasma half-life: Approximately 30 minutes following subcutaneous administration in rodent pharmacokinetic studies. Tissue effects (angiogenesis, VEGF signaling) persist much longer than the plasma window.
• TB-500 plasma half-life: Approximately 2-3 hours due to its larger molecular size (~4963 g/mol) and slower clearance.
• GHK-Cu plasma half-life: Approximately 30 minutes — rapid ligand exchange with serum proteins (albumin, ceruloplasmin) governs clearance kinetics.
• KPV plasma half-life: Approximately 10-15 minutes (small tripeptide). Intracellular anti-inflammatory effects via NF-kB inhibition outlast the plasma window.
• Lyophilized stability: Up to 24 months at -20°C in a sealed vial protected from light and moisture. Up to 4 weeks at 2-8°C without measurable purity loss for any component.
• Reconstituted stability: 14 days at 2-8°C in copper-free polypropylene containers, protected from light. The GHK-Cu component is the rate-limiting peptide — beyond 14 days, gradual loss of copper coordination affects blend integrity.
• Photodegradation: The GHK-Cu copper(II)-peptide complex is photosensitive. Always store and handle reconstituted blend in amber tubes or under low-light conditions.
• Freeze-thaw: Avoid repeated freeze-thaw cycles of reconstituted solution. Aliquot into single-use volumes before freezing if long-term storage is required.
• Incompatibilities: Avoid strong reducing agents, EDTA, and high-affinity copper chelators — they will strip the copper from the GHK-Cu component and disrupt blend activity.

Composition

• Component 1: BPC-157 (Body Protection Compound-157)
• BPC-157 Molecular Formula: C62H98N16O22
• BPC-157 Molecular Weight: 1419.53 g/mol
• Component 2: TB-500 (Thymosin Beta-4 Fragment)
• TB-500 Molecular Formula: C212H350N56O78S
• TB-500 Molecular Weight: 4963.44 g/mol
• Component 3: GHK-Cu (Copper Peptide)
• GHK-Cu Molecular Formula: C14H23N6O4Cu
• GHK-Cu Molecular Weight: 403.92 g/mol
• Component 4: KPV (Alpha-MSH Fragment)
• KPV Molecular Formula: C16H30N4O4
• KPV Molecular Weight: 342.43 g/mol
• Purity: >98% each component (HPLC)
• Appearance: White lyophilized powder

Storage

• Store lyophilized blend at -20C for long-term storage (up to 24 months).
• For short-term storage (up to 4 weeks), refrigerate at 2-8C.
• After reconstitution, store at 2-8C and use within 30 days.
• Avoid repeated freeze-thaw cycles.
• Protect from light and moisture at all times.

Certificate of Analysis

Every batch of KLOW Blend sold by Pepspan undergoes comprehensive multi-component third-party testing. Our Certificate of Analysis (COA) includes individual HPLC purity analysis for all four peptide components (BPC-157, TB-500, GHK-Cu, and KPV), mass spectrometry confirmation of each peptide, endotoxin testing, and sterility verification. COA documentation is available upon request for any batch number. All testing is performed by independent European laboratories to ensure the highest standards of accuracy and reliability.

Current Batch: Pending first shipment

Every batch of KLOW Blend sold by Pepspan is independently tested by Janoshik Analytical (Prague, Czech Republic). HPLC purity analysis, mass spectrometry, and amino acid sequencing are performed for each shipment. Reports are batch-specific — not generic.

Research Disclaimer

All products on this website are sold strictly for research purposes only. Not intended for human or animal consumption. Must be handled by qualified professionals. Keep out of reach of children. By purchasing, you confirm you are a qualified researcher and will use these products solely for scientific research. The KLOW Blend is not approved for human or veterinary use by any regulatory agency. It must not be administered to humans or animals outside of approved clinical trials. Pepspan assumes no liability for any misuse of this product. All handling must comply with local regulations and institutional safety protocols.

Further Research Resources

Additional research articles, comparison guides, and laboratory protocols related to this peptide:

• BPC-157 recovery & healing research overview
• GHK-Cu copper peptide research in Europe
• How to reconstitute lyophilized peptides